The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis by Chung-Shu Lee, Chung-Han Ho, Kuang-Ming Liao, Yu-Cih Wu, Chin-Chung Shu

Subjects: “…Sodium-glucose cotransporter 2 inhibitors…”
Get full text

Real‐world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED–HEART study by Umut Kocabas, Isil Ergin, Veysel Yavuz, Cihan Altın, Mehmet Kaplan, Gülsüm Meral Yılmaz Öztekin, Mustafa Doğduş, Selda Murat, Bektaş Murat, Tarık Kıvrak, Dilay Karabulut, Ersin Kaya, İbrahim Halil Özdemir, Cennet Yıldız, Fatma Özge Salkın, Emre Özçalık, Şeyda Günay Polatkan, Fahri Çakan, Taner Şen, Umut Karabulut, Sinem Çakal, Ersan Oflar, Ümit Yaşar Sinan, Mustafa Yenerçağ, Uğur Önsel Türk

Subjects: Get full text

Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors by Shilpushp Bhosale, Akash Golani, Malini Premkumar Joshi, Atul Prabhakar Kulkarni

Subjects: Get full text

The role of sodium – glucose cotransporter-2 inhibitors in the treatment of different phenotypes of chronic heart failure by M. Yu. Kolesnyk, Ya. Yu. Maistrovych

Subjects: “…sodium-glucose cotransporter-2 inhibitors…”
Get full text

Factors influencing early renal function changes after SGLT2 inhibitors use and its long-term prognosis: a real-world retrospective study by Bing Xie, Nan Ye, Guoqin Wang, Hong Cheng

Subjects: “…Sodium-glucose cotransporter 2 inhibitors…”
Get full text

Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy by Kong Ling-li, Sun Yuan-bo, Wang Xiao-li, Ren Ming-yu, Li Gui-qin

Subjects: “…Sodium-glucose cotransporter 2 inhibitors…”
Get full text

Budget Impact and Cost–Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand by Arunmanakul P, Phodha T, Pinta-ay S, Nimworapan M, Phrommintikul A, Thammatacharee N, Dilokthornsakul P

Subjects: Get full text

Early Initiation of Sodium–Glucose Cotransporter 2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta‐Analysis by Miloud Cherbi, Olivier Lairez, Guillaume Baudry, Paul Gautier, François Roubille, Clément Delmas

Subjects: Get full text

Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study by Min Wang, Mingxia Ye, Maria Lucero, Wanchun Pan, Xin Wang, Heping Zhang, Ling Zhou, Yuanguang Meng

Subjects: “…Sodium-glucose cotransporter-2 inhibitor…”
Get full text

Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis by Sadia Bari, Afroza Rahman, Md Anwar Hossen, KM Saif-Ur-Rahman

Subjects: Get full text

Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients by Lucie Maigret, Lucile Basle, Valérie Chatelet, Laure Ecotiere, Peggy Perrin, Léonard Golbin, Dominique Bertrand, Dany Anglicheau, Coralie Poulain, Cyril Garrouste, Clément Danthu, Charlotte Boud'hors, Yannick Le Meur, Manon Dekeyser, Fabien Duthe, Bénédicte Sautenet, Pierre-Guillaume Deliège, Philippe Gatault

Subjects: Get full text

Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report by Nadia Salerno, Jessica Ielapi, Angelica Cersosimo, Isabella Leo, Assunta Di Costanzo, Giuseppe Armentaro, Salvatore De Rosa, Angela Sciacqua, Sabato Sorrentino, Daniele Torella

Subjects: Get full text

Efficacy and safety of agents for IgA nephropathy: a network meta-analysis of randomized controlled trials by Bo Chen, Bo Chen, Yan Zhu, Yang Yang, Gaosi Xu

Subjects: Get full text

Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis by Michele Maremmani, Ramin Ebrahimi, Marco Centola, Felice Achilli, Valentina Capone, Eduardo Bossone, Christian Templin, Davide Di Vece

Subjects: “…Sodium–glucose cotransporter-2 inhibitors…”
Get full text

Progress in studies on renal effects and molecular mechanism of SGLT-2 inhibitors by XING Bei, WANG Xin-ling

Subjects: “…Sodium-glucose cotransporter 2 inhibitors…”
Get full text

Mechanisms of acute renal injury caused by SGLT-2 inhibitor in patients with diabetes mellitus by Gong Yan, He Qiao-yan, Yang Xiao-juan

Subjects: “…Sodium-glucose cotransporter-2 inhibitor…”
Get full text

SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis by Koji Nagayama, Risako Harada, Hiroshi Ajima, Sakurako Orikasa, Misaki Aoshima, Yutaka Oki

Subjects: Get full text

SGLT2 inhibitors in lupus nephritis: a multicentric study in Latin America by José L. Daza, Gerardo Gutiérrez, Rosa L. Peñuela-Murcia, Andrés Cárdenas, Juan S. Reyes-Bello

Subjects: “…Lupus nephritis. Sodium-glucose cotransporter 2 inhibitors. Antinuclear antibodies. …”
Get full text

Long‐term efficacy of SGLT2 inhibitors for elderly patients with acute decompensated heart failure: The OASIS‐HF study by Michitaka Amioka, Hiroki Kinoshita, Yuto Fuji, Kazuhiro Nitta, Kenichi Yamane, Tomoki Shokawa, Yukiko Nakano

Subjects: Get full text

Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review by Pavitraa Saravana Kumar, Yogapriya Chidambaram, G. Shree Devi, Vettriselvi Venkatesan, Ramesh Sankaran, Nagendra Boopathy Senguttuvan, Thanikachalam Sadagopan, Dorairaj Prabhakaran

Subjects: “…sodium-glucose cotransporter 2 inhibitors…”
Get full text